Saint Luke's Cancer Institute - Boise is a clinical research site located in Boise, Idaho, United States 83712.
Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.
Saint Luke's Cancer Institute - Boise has participated in 334 clinical trials with 249 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Children's Oncology Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Idaho · View every site in Boise
Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Saint Luke's Cancer Institute - Boise has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Saint Luke's Cancer Institute - Boise has 334 clinical trials on record, with 249 currently active. Their work covers B Acute Lymphoblastic Leukemia, Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma.
Saint Luke's Cancer Institute - Boise has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.